320 related articles for article (PubMed ID: 21668337)
1. Insulin preparations with prolonged effect.
Owens DR
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
[TBL] [Abstract][Full Text] [Related]
2. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.
Bolli GB; Andreoli AM; Lucidi P
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S43-52. PubMed ID: 21668336
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
5. Evolution of insulin development: focus on key parameters.
Tibaldi JM
Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
[TBL] [Abstract][Full Text] [Related]
6. Insulin formulations--a review.
Gualandi-Signorini AM; Giorgi G
Eur Rev Med Pharmacol Sci; 2001; 5(3):73-83. PubMed ID: 12004916
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemia rates with basal insulin analogs.
Little S; Shaw J; Home P
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S53-64. PubMed ID: 21668338
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered insulin analogs: diabetes in the new millenium.
Vajo Z; Duckworth WC
Pharmacol Rev; 2000 Mar; 52(1):1-9. PubMed ID: 10699152
[TBL] [Abstract][Full Text] [Related]
9. Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.
Lam S
Heart Dis; 2003; 5(3):231-40. PubMed ID: 12783637
[TBL] [Abstract][Full Text] [Related]
10. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
11. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
Owens DR; Matfin G; Monnier L
Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
[TBL] [Abstract][Full Text] [Related]
12. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
Gerich JE
Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
[TBL] [Abstract][Full Text] [Related]
13. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
14. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
15. The future of basal insulin supplementation.
Simon AC; DeVries JH
Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S103-8. PubMed ID: 21568722
[TBL] [Abstract][Full Text] [Related]
16. Insulin glargine (Lantus).
Owens DR; Griffiths S
Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
[TBL] [Abstract][Full Text] [Related]
17. Synthetic insulin analogs and their use in dogs and cats.
Gilor C; Graves TK
Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):297-307. PubMed ID: 20219490
[TBL] [Abstract][Full Text] [Related]
18. Insulin analogues in the management of diabetes.
Vázquez-Carrera M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
Bolli GB
Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
[TBL] [Abstract][Full Text] [Related]
20. Long-acting insulin analogs.
Rosskamp RH; Park G
Diabetes Care; 1999 Mar; 22 Suppl 2():B109-13. PubMed ID: 10097910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
